Real-world experience of ocrelizumab in multiple sclerosis in an Arab population

Beatriz Garcia-Cañibanoa Department of Neurology, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar;b Weill Cornell Medical College, Doha, QatarCorrespondence[email protected]

Sami Ouanesc Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar

Gowrii Saswathy Ganesanb Weill Cornell Medical College, Doha, Qatar

https://orcid.org/0000-0002-9039-8387

Wajiha Yousufb Weill Cornell Medical College, Doha, Qatar

Basel Humosb Weill Cornell Medical College, Doha, Qatar

Tehniyat Baigb Weill Cornell Medical College, Doha, Qatar

Faiza Ibrahimd Clinical Services Unit, Hamad Medical Corporation, Doha, Qatar

Rajvir Singhe Cardiology Research Center, Heart Hospital, Hamad Medical Corporation, Doha, Qatar

Dirk Deleua Department of Neurology, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar;b Weill Cornell Medical College, Doha, Qatar

show all

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Real-world experience of ocrelizumab in multiple sclerosis in an Arab population

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Real-world experience of ocrelizumab in multiple sclerosis in an Arab population

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date